Skip to main content

Table 3 Disease-specific survival (DSS) for GIST patients <50 years (sub-cohort I, “young” ) versus ≥50 years (sub-cohort II, “old” ) related to GIST relevant clinicopathological parameters

From: Impact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST)

Parameter

 

Disease-specific survival (DSS) rates

p-value1

  

Sub-cohort I (“young”)

Sub-cohort II (“old”)

 

n = 87

n = 125

  

1 yr

3 yr

5 yr

1 yr

3 yr

5 yr

 

Sex

male

96.9%

92,3%

92,3%

97,8%

84,8%

78,5%

0.326

 

female

100%

100%

100%

94,7%

88,6%

83,2%

0.008

 

p-value 2

 

0.033

  

0.596

  

Localization

Gaster

97,2%

97,2%

97,2%

97,0%

88,0%

83,4%

0.036

 

Small intestine

100%

93,8%

93,8%

96,4%

88,5%

78,6%

0.267

 

p-value 2

 

0.225

  

0.813

  

Histotype

Spindle

100%

97,4%

97,4%

96,4%

90,8%

83,5%

0.028

 

epitheliod/mixed

100%

100%

100%

91,7%

66,7%

66,7%

0.061

 

p-value 2

 

0.695

  

0.097

  

Size

<1 cm

-

-

-

100,0%

100,0%

85,7%

-

 

≥1 cm

100%

97,9%

97,9%

96,6%

87,5%

82,6%

0.012

 

p-value 2

 

-

  

0.499

  

Size

<5 cm

96,8%

92,2%

92,2%

100,0%

94,5%

90,9%

0.630

 

≥5 cm

100%

100%

100%

94,1%

83,8%

76,3%

0.008

 

p-value 2

 

0.462

  

0.012

  

Size

<10 cm

97,9%

95,0%

95,0%

98,6%

95,3%

93,1%

0.839

 

≥10 cm

100%

100%

100%

92,0%

71,1%

56,0%

0.010

 

p-value 2

 

0.759

  

<0.001

  

Mitotic rate

<5 / 50 HPF

100%

100%

100%

98,4%

96,2%

90,4%

0.131

 

≥5 / 50 HPF

100%

100%

100%

91,6%

73,7%

66,7%

0.026

 

p-value 2

 

0.038

  

0.001

  

Mitotic rate

<10 / 50 HPF

100%

100%

100%

97,4%

92,4%

88,2%

0.043

 

≥10 / 50 HPF

100%

100%

100%

89,7%

68,6%

56,1%

0.025

 

p-value 2

 

<0.001

  

<0.001

  

Risk (NIH)

high

100%

100%

100%

87,9%

68,4%

60,8%

0.004

 

non-high

100%

100%

100%

100,0%

98,0%

92,9%

0.227

 

p-value

 

0.027

  

<0.001

  

Risk (AFIP)

high

100%

100%

100%

89,4%

70,5%

61,7%

0.018

 

non-high

100%

100%

100%

98,5%

94,4%

89,4%

0.084

 

p-value

 

0.013

  

<0.001

  
  1. 1Unadjustedp-values comparing data from study-cohort I vs. II considering DSS after 5 year follow-up.
  2. 2Unadjusted p-values comparing data within study-cohort I and II considering DSS rates after 5 year follow-up.